Controlled Release of LL-37-Derived Synthetic Antimicrobial and Anti-Biofilm Peptides SAAP-145 and SAAP-276 Prevents Experimental Biomaterial-Associated Staphylococcus aureus Infection
Name
Email Adress
I am interested in… —Please choose an option—Learning morePartnership opportunitiesInvestor Relations and Media inquiriesCareer opportunitiesOther
Message
Your information will be processed in accordance with the Privacy Policy.
